{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:49:54Z","timestamp":1774673394522,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,4,7]],"date-time":"2003-04-07T00:00:00Z","timestamp":1049673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1038\/ni910","type":"journal-article","created":{"date-parts":[[2003,4,28]],"date-time":"2003-04-28T13:42:21Z","timestamp":1051537341000},"page":"471-477","source":"Crossref","is-referenced-by-count":283,"title":["Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock"],"prefix":"10.1038","volume":"4","author":[{"given":"Marina","family":"Karaghiosoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Steinborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Kriegsh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Baccarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Donabauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Reichart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kolbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bogdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Leanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,7]]},"reference":[{"key":"BFni910_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1004","volume":"3","author":"B Beutler","year":"2003","unstructured":"Beutler, B. & Rietschel, E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3, 169\u2013176 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni910_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan, C. Nitric oxide and the immune response. Nat. Immunol. 2, 907\u2013916 (2001).","journal-title":"Nat. Immunol."},{"key":"BFni910_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1286-4579(02)01613-1","volume":"4","author":"MA Dobrovolskaia","year":"2002","unstructured":"Dobrovolskaia, M.A. & Vogel, S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Inf. 4, 903\u2013914 (2002).","journal-title":"Microbes Inf."},{"key":"BFni910_CR4","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"BFni910_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0952-7915(02)00013-4","volume":"15","author":"S Akira","year":"2003","unstructured":"Akira, S. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15, 5\u201311 (2003).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni910_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature01180","volume":"420","author":"T Horng","year":"2002","unstructured":"Horng, T., Barton, G.M., Flavell, R.A. & Medzhitov, R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329\u2013332 (2002).","journal-title":"Nature"},{"key":"BFni910_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature01182","volume":"420","author":"M Yamamoto","year":"2002","unstructured":"Yamamoto, M. et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324\u2013329 (2002).","journal-title":"Nature"},{"key":"BFni910_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1074-7613(00)80086-2","volume":"11","author":"T Kawai","year":"1999","unstructured":"Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115\u2013122 (1999).","journal-title":"Immunity"},{"key":"BFni910_CR9","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.4049\/jimmunol.167.10.5887","volume":"167","author":"T Kawai","year":"2001","unstructured":"Kawai, T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887\u20135894 (2001).","journal-title":"J. Immunol."},{"key":"BFni910_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","volume":"56","author":"S Pestka","year":"1987","unstructured":"Pestka, S., Langer, J.A., Zoon, K.C. & Samuel, C.E. Interferons and their actions. Annu. Rev. Biochem. 56, 727\u2013777 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"BFni910_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI0215770","volume":"109","author":"T Decker","year":"2002","unstructured":"Decker, T., Stockinger, S., Karaghiosoff, M., M\u00fcller, M. & Kovarik, P. IFNs and Stats in innate immunity to microorganisms. J. Clin. Invest. 109, 1271\u20131277 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFni910_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0952-7915(00)00111-4","volume":"12","author":"C Bogdan","year":"2000","unstructured":"Bogdan, C. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12, 419\u2013424 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni910_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ni774","volume":"3","author":"V Toshchakov","year":"2002","unstructured":"Toshchakov, V. et al. TLR4, but not TLR2, mediates IFN-\u03b2\u2013induced Stat1\u03b1\/\u03b2-dependent gene expression in macrophages. Nat. Immunol. 3, 392\u2013398 (2002).","journal-title":"Nat. Immunol."},{"key":"BFni910_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy, D.E. & Darnell, J.E.J. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651\u2013662 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFni910_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S1074-7613(00)00055-8","volume":"13","author":"K Shimoda","year":"2000","unstructured":"Shimoda, K. et al. Tyk2 plays a restricted role in IFN \u03b1 signaling, although it is required for IL-12\u2013mediated T cell function. Immunity 13, 561\u2013571 (2000).","journal-title":"Immunity"},{"key":"BFni910_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1074-7613(00)00054-6","volume":"13","author":"M Karaghiosoff","year":"2000","unstructured":"Karaghiosoff, M. et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13, 549\u2013560 (2000).","journal-title":"Immunity"},{"key":"BFni910_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.157.1.291","volume":"157","author":"G Fantuzzi","year":"1996","unstructured":"Fantuzzi, G. et al. Effect of endotoxin in IL-1 \u03b2-deficient mice. J. Immunol. 157, 291\u2013296 (1996).","journal-title":"J. Immunol."},{"key":"BFni910_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0304-3940(99)00953-2","volume":"281","author":"LA Kobierski","year":"2000","unstructured":"Kobierski, L.A., Srivastava, S. & Borsook, D. Systemic lipopolysaccharide and interleukin-1\u03b2 activate the interleukin 6: STAT intracellular signaling pathway in neurons of mouse trigeminal ganglion. Neurosci. Lett. 281, 61\u201364 (2000).","journal-title":"Neurosci. Lett."},{"key":"BFni910_CR19","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1128\/IAI.65.11.4734-4737.1997","volume":"65","author":"F Mattner","year":"1997","unstructured":"Mattner, F. et al. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12\u2013dependent shock but not from tumor necrosis factor \u03b1-dependent shock. Infect. Immun. 65, 4734\u20134737 (1997).","journal-title":"Infect. Immun."},{"key":"BFni910_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","volume":"73","author":"K Pfeffer","year":"1993","unstructured":"Pfeffer, K. et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457\u2013467 (1993).","journal-title":"Cell"},{"key":"BFni910_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/364798a0","volume":"364","author":"J Rothe","year":"1993","unstructured":"Rothe, J. et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF- mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798\u2013802 (1993).","journal-title":"Nature"},{"key":"BFni910_CR22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1126\/science.3895437","volume":"299","author":"B Beutler","year":"1985","unstructured":"Beutler, B., Milsark, I.W. & Cerami, A. Passive immunization against cachectin\/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 299, 869\u2013871 (1985).","journal-title":"Science"},{"key":"BFni910_CR23","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1093\/emboj\/17.22.6660","volume":"17","author":"I Marie","year":"1998","unstructured":"Marie, I., Durbin, J.E. & Levy, D.E. Differential viral induction of distinct interferon-\u03b1 genes by positive feedback through interferon regulatory factor-7. EMBO J. 17, 6660\u20136669 (1998).","journal-title":"EMBO J."},{"key":"BFni910_CR24","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1128\/IAI.68.3.1600-1607.2000","volume":"68","author":"A Sing","year":"2000","unstructured":"Sing, A. et al. Bacterial induction of \u03b2 interferon in mice is a function of the lipopolysaccharide component. Infect. Immun. 68, 1600\u20131607 (2000).","journal-title":"Infect. Immun."},{"key":"BFni910_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1359-6101(00)00032-0","volume":"12","author":"M Sato","year":"2001","unstructured":"Sato, M., Taniguchi, T. & Tanaka, N. The interferon system and interferon regulatory factor transcription factors \u2013 studies from gene knockout mice. Cytokine Growth Factor Rev. 12, 133\u2013142 (2001).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFni910_CR26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.69.4.598","volume":"69","author":"Y Ohmori","year":"2001","unstructured":"Ohmori, Y. & Hamilton, T.A. Requirement for STAT1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 69, 598\u2013604 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"BFni910_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","volume":"84","author":"JE Durbin","year":"1996","unstructured":"Durbin, J.E., Hackenmiller, R., Simon, M.C. & Levy, D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443\u2013450 (1996).","journal-title":"Cell"},{"key":"BFni910_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0960-9822(98)70086-7","volume":"8","author":"L Erlandsson","year":"1998","unstructured":"Erlandsson, L. et al. Interferon-\u03b2 is required for interferon-\u03b1 production in mouse fibroblasts. Curr. Biol. 8, 223\u2013226 (1998).","journal-title":"Curr. Biol."},{"key":"BFni910_CR29","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)\u2013deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749\u20133752 (1999).","journal-title":"J. Immunol."},{"key":"BFni910_CR30","first-page":"407","volume":"4","author":"A Haziot","year":"1996","unstructured":"Haziot, A. et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Cell 4, 407\u2013414 (1996).","journal-title":"Cell"},{"key":"BFni910_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ni809","volume":"3","author":"Y Nagai","year":"2002","unstructured":"Nagai, Y. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3, 667\u2013672 (2002).","journal-title":"Nat. Immunol."},{"key":"BFni910_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature736","volume":"416","author":"N Suzuki","year":"2002","unstructured":"Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750\u2013756 (2002).","journal-title":"Nature"},{"key":"BFni910_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/372560a0","volume":"372","author":"SL Erickson","year":"1994","unstructured":"Erickson, S.L. et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2\u2013deficient mice. Nature 372, 560\u2013563 (1994).","journal-title":"Nature"},{"key":"BFni910_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0092-8674(95)90085-3","volume":"81","author":"JD MacMicking","year":"1995","unstructured":"MacMicking, J.D. et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641\u2013650 (1995).","journal-title":"Cell"},{"key":"BFni910_CR35","doi-asserted-by":"publisher","first-page":"10688","DOI":"10.1073\/pnas.92.23.10688","volume":"92","author":"VE Laubach","year":"1995","unstructured":"Laubach, V.E., Shesely, E.G., Smithies, O. & Sherman, P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92, 10688\u201310692 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni910_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1074-7613(00)00053-4","volume":"13","author":"M Sato","year":"2000","unstructured":"Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-\u03b1\/\u03b2 gene induction. Immunity 13, 539\u2013548 (2000).","journal-title":"Immunity"},{"key":"BFni910_CR37","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1128\/JVI.74.7.3404-3409.2000","volume":"74","author":"R Deonarain","year":"2000","unstructured":"Deonarain, R. et al. Impaired antiviral response and \u03b1\/\u03b2 interferon induction in mice lacking \u03b2 interferon. J. Virol. 74, 3404\u20133409 (2000).","journal-title":"J. Virol."},{"key":"BFni910_CR38","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1126\/science.288.5475.2357","volume":"288","author":"A Takaoka","year":"2000","unstructured":"Takaoka, A. et al. Cross talk between intferferon-\u03b3 and -\u03b1\/\u03b2 signaling components in calveolar membrane domains. Science 288, 2357\u20132360 (2000).","journal-title":"Science"},{"key":"BFni910_CR39","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4049\/jimmunol.165.2.618","volume":"165","author":"M Hirschfeld","year":"2000","unstructured":"Hirschfeld, M., Ma, Y., Weis, J.H., Vogel, S.N. & Weis, J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165, 618\u2013622 (2000).","journal-title":"J. Immunol."},{"key":"BFni910_CR40","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1172\/JCI0214704","volume":"109","author":"V Supajatura","year":"2002","unstructured":"Supajatura, V. et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109, 1351\u20131359 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFni910_CR41","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1128\/IAI.69.3.1477-1482.2001","volume":"69","author":"M Hirschfeld","year":"2001","unstructured":"Hirschfeld, M. et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69, 1477\u20131482 (2001).","journal-title":"Infect. Immun."},{"key":"BFni910_CR42","doi-asserted-by":"publisher","first-page":"35535","DOI":"10.1074\/jbc.274.50.35535","volume":"274","author":"L Navarro","year":"1999","unstructured":"Navarro, L. & David, M. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J. Biol. Chem. 274, 35535\u201335538 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFni910_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0014-5793(02)02636-4","volume":"571","author":"N Shinobu","year":"2002","unstructured":"Shinobu, N. et al. Involvement of TIRAP\/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide. FEBS Lett. 571, 251\u2013256 (2002).","journal-title":"FEBS Lett."},{"key":"BFni910_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1074\/jbc.M007790200","volume":"276","author":"MJ Servant","year":"2001","unstructured":"Servant, M.J. et al. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276, 355\u2013363 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFni910_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","volume":"17","author":"SE Doyle","year":"2002","unstructured":"Doyle, S.E. et al. IRF3 mediates a TLR3\/TLR4-specific antiviral program. Immunity 17, 251\u2013263 (2002).","journal-title":"Immunity"},{"key":"BFni910_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1074-7613(00)80413-6","volume":"4","author":"J Magram","year":"1996","unstructured":"Magram, J. et al. IL-12\u2013deficient mice are defective in IFN \u03b3 production and type 1 cytokine responses. Immunity 4, 471\u2013481 (1996).","journal-title":"Immunity"},{"key":"BFni910_CR47","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.4049\/jimmunol.157.10.4521","volume":"157","author":"FP Heinzel","year":"1996","unstructured":"Heinzel, F.P., Rerko, R.M., Ahmed, F. & Hujer, A.M. IFN-\u03b3-independent production of IL-12 during murine endotoxemia. J. Immunol. 157, 4521\u20134528 (1996).","journal-title":"J. Immunol."},{"key":"BFni910_CR48","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.4049\/jimmunol.166.5.3075","volume":"166","author":"H Schindler","year":"2001","unstructured":"Schindler, H., Lutz, M.B., Rollinghoff, M. & Bogdan, C. The production of IFN-\u03b3 by IL-12\/IL-18\u2013activated macrophages requires STAT4 signaling and is inhibited by IL-4. J. Immunol. 166, 3075\u20133082 (2001).","journal-title":"J. Immunol."},{"key":"BFni910_CR49","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1128\/IAI.68.6.3502-3508.2000","volume":"68","author":"P Hochholzer","year":"2000","unstructured":"Hochholzer, P., Lipford, G.B., Wagner, H., Pfeffer, K. & Heeg, K. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18\u2013deficient mice. Infect. Immun. 68, 3502\u20133508 (2000).","journal-title":"Infect. Immun."},{"key":"BFni910_CR50","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1182\/blood.V99.6.2094","volume":"99","author":"K Shimoda","year":"2002","unstructured":"Shimoda, K. et al. Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice. Blood 99, 2094\u20132099 (2002).","journal-title":"Blood"},{"key":"BFni910_CR51","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.4049\/jimmunol.169.4.1665","volume":"169","author":"MA Freudenberg","year":"2002","unstructured":"Freudenberg, M.A. et al. A murine, IL-12\u2013independent pathway of IFN-\u03b3 induction by gram-negative bacteria based on Stat4 activation by type I IFN and IL-18 signaling. J. Immunol. 169, 1665\u20131668 (2002).","journal-title":"J. Immunol."},{"key":"BFni910_CR52","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1126\/science.1074900","volume":"297","author":"KB Nguyen","year":"2002","unstructured":"Nguyen, K.B. et al. Critical role for Stat4 activation by type I interferons in the interferon-\u03b3 response to viral infection. Science 297, 2063\u20132066 (2002).","journal-title":"Science"},{"key":"BFni910_CR53","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1084\/jem.179.5.1437","volume":"179","author":"BD Car","year":"1994","unstructured":"Car, B.D. et al. Interferon _ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437\u20131444 (1994).","journal-title":"J. Exp. Med."},{"key":"BFni910_CR54","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/35073080","volume":"2","author":"T Taniguchi","year":"2001","unstructured":"Taniguchi, T. & Takaoka, A. A weak signal for strong responses: interferon-\u03b1\/\u03b2 revisited. Nat. Rev. Mol. Cell Biol. 2, 378\u2013386 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFni910_CR55","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1084\/jem.190.10.1451","volume":"190","author":"C-K Lee","year":"1999","unstructured":"Lee, C.-K., Gimeno, R. & Levy, D.E. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes. J. Exp. Med. 190, 1451\u20131463 (1999).","journal-title":"J. Exp. Med."},{"key":"BFni910_CR56","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.4049\/jimmunol.169.12.6668","volume":"169","author":"M Yamamoto","year":"2002","unstructured":"Yamamoto, M. et al. Cutting edge: a novel Toll\/IL-1 receptor domain\u2013containing adapter that preferentially activates the IFN-b promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668\u20136672 (2002).","journal-title":"J. Immunol."},{"key":"BFni910_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni886","volume":"4","author":"H Oshiumi","year":"2003","unstructured":"Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3\u2013mediated interferon-\u03b2 induction. Nat. Immunol. 4, 161\u2013167 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni910_CR58","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.165.3.657","volume":"165","author":"V Lehmann","year":"1987","unstructured":"Lehmann, V., Freudenberg, M.A. & Galanos, C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine\u2013treated mice. J. Exp. Med. 165, 657\u2013663 (1987).","journal-title":"J. Exp. Med."},{"key":"BFni910_CR59","first-page":"615","volume":"41","author":"HH Schmidt","year":"1992","unstructured":"Schmidt, H.H., Warner, T.D., Nakane, M., Forstermann, U. & Murad, F. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41, 615\u2013624 (1992).","journal-title":"Mol. Pharmacol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni910","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:53:30Z","timestamp":1684450410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,7]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["BFni910"],"URL":"https:\/\/doi.org\/10.1038\/ni910","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,7]]}}}